Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real-world study. Authors' reply

Yao Chun Hsu; Chun Ying Wu

doi:10.1111/apt.17644

Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real-world study. Authors' reply

^*此作品的通信作者

研究成果: Editorial

原文	English
頁（從 - 到）	550-551
頁數	2
期刊	Alimentary Pharmacology and Therapeutics
卷	58
發行號	5
DOIs	https://doi.org/10.1111/apt.17644
出版狀態	Published - 9月 2023

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1111/apt.17644

其它文件與鏈接

Link to publication in Scopus

引用此

@article{8e1c173c92a34857a67349a0291776f2,

title = "Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real-world study. Authors' reply",

author = "Hsu, {Yao Chun} and Wu, {Chun Ying}",

year = "2023",

month = sep,

doi = "10.1111/apt.17644",

language = "English",

volume = "58",

pages = "550--551",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Editorial

T2 - Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real-world study. Authors' reply

AU - Hsu, Yao Chun

AU - Wu, Chun Ying

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85167416190&partnerID=8YFLogxK

U2 - 10.1111/apt.17644

DO - 10.1111/apt.17644

M3 - Editorial

C2 - 37559518

AN - SCOPUS:85167416190

SN - 0269-2813

VL - 58

SP - 550

EP - 551

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 5

ER -